Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(15 sites)
United States
Florida Cancer Specialists, Sarasota, Florida Start Midwest, Grand Rapids, Michigan Washington University School Of Medicine, St Louis, Missouri Perlmutter Cancer Center at NYU Langone Brooklyn, Brooklyn, New York Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola, New York NYU Langone Health, New York, New York Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia, Pennsylvania Australia
Icon Cancer Centre Kurralta Park, Kurralta Park Macquarie University, Macquarie University Peter MacCallum Cancer Centre, Melbourne Princess Alexandra Hospital, Woolloongabba Spain
Hosp Univ Vall D Hebron, Barcelona Hosp Univ Fund Jimenez Diaz, Madrid Hosp. Univ. 12 de Octubre, Madrid Hosp Univ Hm Sanchinarro, Madrid